Cargando…
Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study
INTRODUCTION: In December, 2019, an outbreak of the coronavirus disease 2019 (COVID-19), which was caused by a novel coronavirus, started in Wuhan, China. So far, there is limited clinical evidence on the effect of corticosteroid therapy for this disease. This study aims to investigate the associati...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520508/ https://www.ncbi.nlm.nih.gov/pubmed/32986226 http://dx.doi.org/10.1007/s40121-020-00337-y |
_version_ | 1783587790866350080 |
---|---|
author | Ding, Cheng Feng, Xuewen Chen, Yanfei Yuan, Jing Yi, Ping Li, Yongtao Ni, Qin Zou, Rongrong Li, Xiaohe Sheng, Jifang Li, Lanjuan Xu, Kaijin |
author_facet | Ding, Cheng Feng, Xuewen Chen, Yanfei Yuan, Jing Yi, Ping Li, Yongtao Ni, Qin Zou, Rongrong Li, Xiaohe Sheng, Jifang Li, Lanjuan Xu, Kaijin |
author_sort | Ding, Cheng |
collection | PubMed |
description | INTRODUCTION: In December, 2019, an outbreak of the coronavirus disease 2019 (COVID-19), which was caused by a novel coronavirus, started in Wuhan, China. So far, there is limited clinical evidence on the effect of corticosteroid therapy for this disease. This study aims to investigate the association between corticosteroid therapy and the duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) clearance among patients with mild COVID-19. METHODS: Patients with mild COVID-19 were enrolled from two medical centers in China between January 13, 2020 and February 29, 2020. Baseline characteristics and durations of RNA clearance were compared between the corticosteroid and non-corticosteroid therapy groups. The independent effects of corticosteroid therapy on the duration of RNA clearance were estimated by generalized linear models. RESULTS: Of 82 patients with a mild infection, 40 patients were male (48.8%), with a median age of 49 years (interquartile range, IQR 36–61). Among those patients, 36 patients (43.9%) received corticosteroid therapy. The adjusted multivariate models showed that the effects of corticosteroids were non-significant on the durations of onset to first RNA clearance [β 2.48, 95% CI (95% confidence interval) − 0.42 to 5.38, P = 0.0926] and to persistent RNA clearance (β 1.54, 95% CI − 1.41 to 4.48, P = 0.3016), and durations of therapy to first RNA clearance (β 2.16, 95% CI − 0.56 to 4.89, P = 0.1184) and to persistent RNA clearance (β 1.22, 95% CI − 1.52 to 3.95, P = 0.3787). CONCLUSIONS: Corticosteroid therapy in patients with mild COVID-19 was not associated with the duration of SARS-CoV-2 clearance, suggesting that the use of corticosteroids may not be beneficial for patients with mild COVID-19 and should be prudently recommended in clinical practice. However, further studies are needed to verify the findings. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40121-020-00337-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7520508 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-75205082020-09-28 Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study Ding, Cheng Feng, Xuewen Chen, Yanfei Yuan, Jing Yi, Ping Li, Yongtao Ni, Qin Zou, Rongrong Li, Xiaohe Sheng, Jifang Li, Lanjuan Xu, Kaijin Infect Dis Ther Original Research INTRODUCTION: In December, 2019, an outbreak of the coronavirus disease 2019 (COVID-19), which was caused by a novel coronavirus, started in Wuhan, China. So far, there is limited clinical evidence on the effect of corticosteroid therapy for this disease. This study aims to investigate the association between corticosteroid therapy and the duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) clearance among patients with mild COVID-19. METHODS: Patients with mild COVID-19 were enrolled from two medical centers in China between January 13, 2020 and February 29, 2020. Baseline characteristics and durations of RNA clearance were compared between the corticosteroid and non-corticosteroid therapy groups. The independent effects of corticosteroid therapy on the duration of RNA clearance were estimated by generalized linear models. RESULTS: Of 82 patients with a mild infection, 40 patients were male (48.8%), with a median age of 49 years (interquartile range, IQR 36–61). Among those patients, 36 patients (43.9%) received corticosteroid therapy. The adjusted multivariate models showed that the effects of corticosteroids were non-significant on the durations of onset to first RNA clearance [β 2.48, 95% CI (95% confidence interval) − 0.42 to 5.38, P = 0.0926] and to persistent RNA clearance (β 1.54, 95% CI − 1.41 to 4.48, P = 0.3016), and durations of therapy to first RNA clearance (β 2.16, 95% CI − 0.56 to 4.89, P = 0.1184) and to persistent RNA clearance (β 1.22, 95% CI − 1.52 to 3.95, P = 0.3787). CONCLUSIONS: Corticosteroid therapy in patients with mild COVID-19 was not associated with the duration of SARS-CoV-2 clearance, suggesting that the use of corticosteroids may not be beneficial for patients with mild COVID-19 and should be prudently recommended in clinical practice. However, further studies are needed to verify the findings. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40121-020-00337-y) contains supplementary material, which is available to authorized users. Springer Healthcare 2020-09-28 2020-12 /pmc/articles/PMC7520508/ /pubmed/32986226 http://dx.doi.org/10.1007/s40121-020-00337-y Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Original Research Ding, Cheng Feng, Xuewen Chen, Yanfei Yuan, Jing Yi, Ping Li, Yongtao Ni, Qin Zou, Rongrong Li, Xiaohe Sheng, Jifang Li, Lanjuan Xu, Kaijin Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study |
title | Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study |
title_full | Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study |
title_fullStr | Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study |
title_full_unstemmed | Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study |
title_short | Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study |
title_sort | effect of corticosteroid therapy on the duration of sars-cov-2 clearance in patients with mild covid-19: a retrospective cohort study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520508/ https://www.ncbi.nlm.nih.gov/pubmed/32986226 http://dx.doi.org/10.1007/s40121-020-00337-y |
work_keys_str_mv | AT dingcheng effectofcorticosteroidtherapyonthedurationofsarscov2clearanceinpatientswithmildcovid19aretrospectivecohortstudy AT fengxuewen effectofcorticosteroidtherapyonthedurationofsarscov2clearanceinpatientswithmildcovid19aretrospectivecohortstudy AT chenyanfei effectofcorticosteroidtherapyonthedurationofsarscov2clearanceinpatientswithmildcovid19aretrospectivecohortstudy AT yuanjing effectofcorticosteroidtherapyonthedurationofsarscov2clearanceinpatientswithmildcovid19aretrospectivecohortstudy AT yiping effectofcorticosteroidtherapyonthedurationofsarscov2clearanceinpatientswithmildcovid19aretrospectivecohortstudy AT liyongtao effectofcorticosteroidtherapyonthedurationofsarscov2clearanceinpatientswithmildcovid19aretrospectivecohortstudy AT niqin effectofcorticosteroidtherapyonthedurationofsarscov2clearanceinpatientswithmildcovid19aretrospectivecohortstudy AT zourongrong effectofcorticosteroidtherapyonthedurationofsarscov2clearanceinpatientswithmildcovid19aretrospectivecohortstudy AT lixiaohe effectofcorticosteroidtherapyonthedurationofsarscov2clearanceinpatientswithmildcovid19aretrospectivecohortstudy AT shengjifang effectofcorticosteroidtherapyonthedurationofsarscov2clearanceinpatientswithmildcovid19aretrospectivecohortstudy AT lilanjuan effectofcorticosteroidtherapyonthedurationofsarscov2clearanceinpatientswithmildcovid19aretrospectivecohortstudy AT xukaijin effectofcorticosteroidtherapyonthedurationofsarscov2clearanceinpatientswithmildcovid19aretrospectivecohortstudy |